http://www.reportbuyer.com/rss.htmlExplore your competitors and realise your potential in the Diagnostics market. Our reports include information on Testing, Companion Markets, Imaging and In Vitro Diagnostics.en-gbReportbuyerservice@reportbuyer.comenquiries@redwiredesign.comhttp://www.reportbuyer.com/pharma_healthcare/diagnostics/point_care_diagnostics_2010_beyond_rapid_testing_crossroads.htmlAs Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality are here. But is healthcare ready? The drive for wellness and the attention surrounding healthcare reform will surely focus attention on rapid diagnostics. However, according to Shara Rosen, RT, M. b0c5dac7546713212c025840b756e825Wed, 11 Nov 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/infectious_disease_testing_market.html'The Infectious Disease Testing Market: Emerging Opportunities and Business Expansion Strategies' is Venture Planning Group's seven-country survey designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding infectious disease testing market, in evaluating emerging opportunities and developing effective business strategies. The report includes the market segmentation analysis of over 70 diseases and viruses in seven countries, assessment of emerging technologies, review of current instrumentation, as well as strategic profiles of leading suppliers and recent market entrants with innovative technologies and products. The infectious disease testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers. d81cda1187d7d85330114f8ebf2fe887Sun, 01 Nov 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/advances_stem_cell_industry_future_impact_innovation_evaluation_commercial_landscape.htmlAn important milestone in the development of stem cell technology occurred in 2007, when researchers induced human cells into a stem cell state using defined genetic factors. These cells are now known as induced pluripotent stem (IPS) cells; they offer an alternative to using embryonic stem cells. This report takes the implications of IPS cells and other developments into account. 32eef5dd0fb57ff3996af4fab8cb1d77Sat, 10 Oct 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/innovations_oncology_diagnostics_technological_advances_growth_opportunities_future_market_outlook.htmlDespite public policy measures to prevent cancer, such as tobacco control and vaccination against HPV, cancer is sure to remain a significant public health problem throughout the 21st century. Indeed, the global demographic shift towards an ageing population and the spread of high tech modern medicine throughout the emerging economies of Asia and (maybe later) Africa, will expand the market for cancer diagnostics globally. Major developments are likely in both the IVD market and in imaging-based modalities, like computed tomography, with the emphasis being upon the personalized medicine approach, where demand will come from physicians, patients and payors – all of whom want more effective treatments and value for money. b84d5aa43814a01567c2f80dece60db0Sat, 10 Oct 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/competitor_analysis_coagulation_factors.htmlThe present Competitive Intelligence Report about Coagulation Factors provides a competitor evaluation in the field of plasma-derived and recombinant coagulation factors for topical or systemic administration to treat hereditary or acquired coagulation disorders as of October 2009. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report The market size of recombinant and plasma-derived coagulation factor products exceeded US$ 7. 793efed9b1e8194e1f9ac83d5bae857cSat, 10 Oct 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/competitor_analysis_vegf_vegf_r_agonists_antagonists.htmlThe present Competitive Intelligence Report about VEGF and VEGF-R agonists and antagonists provides a competitor evaluation in the field of VEGF and its receptor targeting molecules for treatment of cancer, AMD and for neuroprotection as of September 2009. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report. ce63b4e43228691704ae3f1e7d6a641eWed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/uk_diagnostic_imaging_market_analysis_forecasts_2015.htmlGlobalData's "UK Diagnostic Imaging Market Analysis and Forecasts to 2015" report provides key data, information and analysis on the UK diagnostic imaging market. The report provides market landscape, competitive landscape and market trends information on six market categories including Computed Tomography Systems, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems and X-Ray Systems. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. c2c482643d145aa306b02f0b11d41fa7Wed, 09 Sep 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/advanced_digital_diagnostic_medical_imaging_equipment_market_analysis_directions.htmlThis report reviews, analyzes and sizes the analog & advanced digital diagnostic medical imaging equipment and products markets. The study has found interesting information about the important digital diagnostic medical imaging equipment and products that are marketed to hospitals and external medical imaging facilities in the developed world. This report assesses the market and maps the competitors in this market landscape with more than 100 companies identified. 41ea122948eaeb43f12e07685cc54917Fri, 04 Sep 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/u_s_dna_based_diagnostic_test_equipment_market_analysis_directions.htmlDNA-based diagnostics are established in laboratory medicine with many of the top tests run for infectious disease. The U. S. 95f92d15abde3d687019547bf1164e16Wed, 02 Sep 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/coagulation_factors_2009.htmlThe ""Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis"" report is the most complete and up-to-date evaluation and assessment of the recombinant and plasma-derived coagulation factor pipelines. The authors analyze and assess the target pipeline for each of the coagulation factors used for systemic and topical administration. Companies active in the therapeutic coagulation business are evaluated and the strengths, weaknesses, opportunities and threats (SWOT) in their R&D pipeline benchmarked in the respective peer group. 36a8a198da3f7758b8f721b6712a042cSat, 08 Aug 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/ceo_360_degree_perspective_global_clinical_diagnostics_industry.htmlThe CEO 360 Perspective presentation provides a holistic view of the 7 perspectives that affect C-level driven decisions, within the Clinical Diagnostics markets. This includes the global, integrated industry, technology, economic, competitive, customer and best practices perspective. Each perspective provides insight into the current and future trends expected to impact the industry at large. 2a0de3121a84a2cb9db408f484621a00Sat, 08 Aug 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/global_molecular_diagnostics_market.htmlRenub Research report titled "Global Molecular Diagnostics Market: Opportunities & Future Forecast" analysis the global molecular diagnostics market. This research report provides the global molecular diagnostics industry past present and future scenario. The specific clinical segments like Infectious Disease Testing Market, ID/forensics Market, Tissue Typing Market, Oncology Market, Food Testing Market, Genetic Testing Market and Pharmacogenomics Market past, present and future scenario has been analyzed in this report. d2ddd1266f0fe523cac15d084229bd8eSat, 08 Aug 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/over_the_counter_diagnostic_products_world_markets.htmlThe purpose of this TriMark Publications analysis is to describe the specific market segments of the over-the-counter (OTC) diagnostic products and home healthcare markets. It examines the diagnostic measurement devices and their reagents and supplies that are utilized in clinics and by patients directly in their homes to diagnose and monitor disease. This study also includes a review of home healthcare kits and devices that measure health-related conditions. d84c788a5b391bc66a89809fe146ee7aSat, 08 Aug 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/innovations_medical_imaging.htmlMedical imaging technologies are widely used in clinical diagnosis to guide therapeutic and surgical intervention and to monitor disease progression, recurrence and treatment response and to improve surgical navigation. A plethora of imaging modalities are available to the medical community to provide anatomical and functional information. Extensive research indicates that the application of medical imaging may lead to significant reduction in healthcare costs by increasing the speed of diagnosis, avoiding the need for expensive treatments and surgical procedures and reducing mortality rate through early screening programs. ec00f4b103665632c01facf1af71751cSat, 08 Aug 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/infectious_disease_diagnostic_markets.htmlThe ubiquity of infections makes thier detection a healthcare priority and an ongoing opportunity for IVD companies. The aging of the population, and emerging threats - MRSA, swine flu, and others have had an impact on this market recently and will continue to in years to come. Kalorama Information has been observing diagnostic markets for over a decade and has assembled in this report, Infectious Disease Diagnostics, Kalorama Information has assembled its best primary and secondary research. 0c5052e68572d31b22cb2da080b97556Sat, 08 Aug 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/diagnostic_medical_laboratories_us.htmlIndustry diagnosed with growth Displaying the characteristics of an industry in the growth phase of its life cycle, the aging population, a greater focus on early detection and prevention, and an increase in the range of available tests suggests that solid growth is likely to continue. However, industry players will need to keep an eye on substitute services, which have the potential to erode market share. This industry comprises establishments known as medical and diagnostic laboratories primarily engaged in providing analytic or diagnostic services, including body fluid analysis and diagnostic imaging, generally to the medical profession or to the patient on referral from a health practitioner. 2e5a42480ebaf26f088e2d78cdb14859Sat, 08 Aug 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/strategic_analysis_u_s_drugs_abuse_laboratory_testing.htmlThis research service analyzes drugs of abuse laboratory testing services within the United States. The market is further divided into three distinct sub-segments. Each segment covers key market drivers and restraints, market trends, technology trends, competitive structure and revenue forecasts, with a base year of 2008. e06ff84f83dcad2a1dd25dd5672bd8efTue, 07 Jul 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/working_ivd.htmlAs Kalorama Information has examined the markets for year, we have seen the companies whose approaches have succeeded and those who have not been successful. A small pivot in strategy often may have made the difference. We have summed up this knowledge in What is Working in IVD: Successful Commercialization of New Products and Technologies The report is written by Kalorama's lead diagnostic expert, Shara Rosen, R. 2d77bc87c433577f715849760bd9278bTue, 07 Jul 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/molecular_diagnostics_market_trends_opportunities.htmlMolecular diagnostics or the analysis of DNA and RNA at the molecular level - is a fast-growing market, driven by the growing understanding of the human genome. Although a small part of the In-Vitro Diagnostics (IVD) market, molecular diagnostics market is one of the two growth drivers of the IVD industry. In the decision making process of healthcare experts, diagnostics tests have a major influence. 2d147710de1407ec9edede789aeec231Tue, 07 Jul 2009 12:00:00 GBPharma & Healthcare/Diagnosticshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/medical_ultrasound_systems_market_worldwide_2009.htmlThe purpose of this report is to analyze and size the market for Medical Ultrasound Systems Market Worldwide, discuss key players, and identify trends impacting the market for these products. Topics discussed include product definitions, applications and types of ultrasound, market trends, strategies, competition, and key players. The report provides detailed market estimates and forecasts for Ultrasound Systems, related products and maintenance services in U. f7253f03714c7094654f0d90796447e6Tue, 07 Jul 2009 12:00:00 GBPharma & Healthcare/Diagnostics